infecti
bronchiti
viru
ibv
belong
famili
coronavirida
continu
one
econom
import
pathogen
poultri
industri
coronavirus
envelop
virus
posit
sens
rna
genom
rang
kb
two
third
coronaviru
genom
encod
replicas
activ
includ
viral
rnadepend
rna
polymeras
rdrp
helicas
viral
proteinas
remain
one
third
genom
encod
structur
protein
small
groupspecif
orf
recent
occasion
outbreak
infecti
bronchiti
ib
remain
one
import
poultri
diseas
mani
countri
world
consequ
studi
exploitur
effect
antiibv
medicin
signific
valu
broad
interest
ibv
four
essenti
structur
protein
three
membran
protein
spike
integr
membran
small
envelop
e
protein
phosphoryl
nucleocapsid
n
protein
protein
interact
cellular
receptor
induc
cell
viral
membran
fusion
e
protein
local
ergolgi
intermedi
compart
consid
play
critic
role
viral
bud
n
protein
interact
viral
genom
rna
form
ribonucleocapsid
rnp
complex
associ
replic
transcript
highli
immunogen
phosphoprotein
also
implic
viral
genom
replic
modul
cell
signal
pathway
ntermin
nprotein
ntd
serv
function
unit
critic
specif
interact
rna
exhibit
ushap
structur
two
arm
rich
basic
residu
addit
key
function
residu
ntd
highli
conserv
among
coronavirus
differ
antigen
group
n
protein
major
protein
target
explor
antiibv
medicin
aromat
medicin
plant
produc
essenti
oil
contain
hydrocarbon
oxygen
deriv
fact
essenti
oil
wide
use
tradit
medicin
among
other
antibacteri
antifung
immunomodulatori
antiinflammatori
antirheumat
activ
describ
pinen
figur
major
compon
turpentin
byproduct
pulp
make
industri
recent
clinic
research
shown
present
antimicrobi
activ
best
knowledg
antiibv
activ
pinen
evalu
yet
therefor
aim
present
studi
evalu
antiibv
activ
mtt
assay
furthermor
explicitli
solvat
flexibl
dock
molecular
dynam
md
method
appli
investig
inhibitori
mechan
two
compound
ibv
n
protein
anticip
insight
understand
bind
mechan
valu
ration
design
ibv
inhibitor
monolay
cultur
vero
cell
grown
mm
pinenecontain
medium
h
incub
cell
viabil
determin
mtt
assay
cytotox
vero
cell
express
shown
tabl
valu
mm
show
higher
maximum
noncytotox
concentr
mm
mm
two
valu
much
higher
ribavirin
mm
p
result
indic
compar
ribavirin
possess
lower
cytotox
vero
cell
thu
could
infer
antivir
effect
due
cytotox
moreov
valu
mm
somewhat
lower
mm
base
valu
select
index
si
calcul
respect
report
si
appropri
antivir
agent
suggest
may
judg
signific
antiibv
activ
identifi
step
replic
might
inhibit
cell
infect
ibv
preincub
cell
ribavirin
posit
control
pinen
pretreat
viru
ribavirin
pinen
prior
infect
addit
synthet
antivir
drug
pinen
adsorpt
adsorpt
intracellular
replic
period
experi
cell
infect
untreat
viru
use
control
percent
reduct
calcul
rel
amount
viru
produc
absenc
drug
shown
figur
ribavirin
show
maximum
antivir
activ
ad
concentr
mm
replic
period
inhibit
viral
replic
ibv
commonli
known
ribavirin
interfer
rna
metabol
requir
viral
replic
howev
signific
effect
detect
ribavirin
use
pretreat
cell
virus
ribavirin
ad
adsorpt
phase
unlik
ribavirin
show
maximum
noncytotox
antivir
activ
ad
concentr
mm
replic
period
inhibit
viral
replic
ibv
wherea
also
show
inhibit
pretreat
viru
phase
similarli
also
show
signific
antiibv
inhibit
replic
period
pretreat
viru
phase
inhibit
result
suggest
inhibit
pinen
ibv
appear
moder
occur
enter
cell
much
stronger
occur
penetr
viru
cell
addit
biochem
studi
indic
bioactiv
n
protein
import
target
replic
ibv
viru
henc
infer
n
protein
may
suppress
pinen
conclus
possess
antiibv
properti
hinder
bind
process
rna
ibv
nprotein
result
support
potenti
use
treatment
ibv
infecti
diseas
studi
antiibv
mechan
need
support
point
view
therefor
explicit
solvent
dock
molecular
dynam
md
simul
use
explor
inhibit
mechan
ntd
tri
elucid
activ
differ
shown
figur
total
energi
backboneatom
rmsd
indic
two
dock
complex
reach
equilibrium
ps
remain
rather
stabl
afterward
accordingli
geometr
energet
analys
perform
averag
structur
ps
md
trajectori
superpos
structur
figur
show
occupi
proxim
space
rna
bind
site
ntd
map
loop
region
top
within
protein
howev
bind
mode
differ
interact
energi
einter
ntd
calcul
kcal
van
der
waal
interact
rather
electrostat
interact
play
domin
role
bind
process
contribut
almost
figur
show
cyclohexen
ring
sandwich
residu
exert
strong
interact
valu
esum
amount
kcal
respect
tabl
besid
strong
van
der
waal
interact
evdw
residu
especi
residu
valu
equal
kcal
respect
figur
tabl
fulli
partial
conserv
residu
key
rna
bind
commend
support
viewpoint
hinder
bind
rna
ntd
good
agreement
inhibit
occur
strongli
penetr
viru
host
cell
similarli
bind
mainli
stabil
van
der
waal
interact
interact
energi
einter
ntd
slightli
reduc
kcal
van
der
waal
energi
evdw
own
shown
figur
tabl
strong
van
der
waal
effect
also
observ
cyclohexan
ring
residu
figur
van
der
waal
contribut
evdw
two
residu
calcul
kcal
respect
tabl
maxim
bind
differ
methylen
group
orient
toward
residu
result
situat
van
der
waal
contribut
evdw
residu
sharpli
reduc
kcal
respect
indic
bind
rna
may
interf
effect
lower
consist
experiment
data
taken
togeth
like
exert
antiibv
activ
inhibit
bind
process
rna
ibv
n
protein
former
higher
bioactiv
therefor
potenti
lead
compound
develop
antiibv
agent
studi
antiibv
drug
urgent
need
support
point
view
ribavirin
obtain
sigma
chemic
co
st
loui
mo
usa
store
glass
vial
teflon
seal
cap
absenc
light
african
green
monkey
kidney
cell
purchas
harbin
veterinari
research
institut
harbin
p
r
china
cell
grown
monolay
cultur
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
calf
serum
fc
uml
penicillin
streptomycin
monolay
remov
plastic
surfac
serial
passag
whenev
becam
confluent
cell
plate
onto
cultur
plate
cytotox
antiibv
assay
propag
atmospher
ibv
gray
strain
purchas
nation
control
institut
veterinatori
bioproduct
pharmaceut
beij
p
r
china
viru
routin
grown
cell
ibvgray
stock
cultur
prepar
supernat
infect
cell
store
cellular
toxic
cell
assess
mtt
method
briefli
cell
seed
microtit
plate
absenc
presenc
variou
concentr
mm
mm
eight
replic
incub
humidi
atmospher
h
supernat
discard
wash
pb
twice
mtt
reagent
mgml
pb
ad
well
incub
h
remov
supernat
dmso
ad
incub
anoth
min
plate
read
elisa
reader
thermo
molecular
devic
co
union
citi
usa
nm
mean
od
cell
control
well
assign
valu
maxim
nontox
concentr
cytotox
concentr
calcul
linear
regress
analysi
doserespons
curv
gener
data
inhibit
viru
replic
measur
mtt
method
serial
dilut
treat
viru
adsorb
cell
h
residu
inoculum
discar
infect
cell
ad
dmem
contain
fc
assay
perform
eight
replic
incub
h
cultur
measur
mtt
method
describ
concentr
ribavirin
inhibit
viru
number
determin
doserespons
curv
cell
virus
incub
differ
stage
viral
infect
cycl
order
determin
mode
antivir
action
cell
pretreat
viral
infect
virus
incub
infect
cell
virus
incub
togeth
adsorpt
penetr
viru
host
cell
alway
use
nontox
concentr
cell
monolay
pretreat
prior
inocul
viru
ad
cultur
medium
incub
compound
aspir
cell
wash
immedi
ibv
inoculum
ad
pretreat
viru
ibv
incub
medium
contain
room
temperatur
prior
infect
cell
analyz
antiibv
inhibit
adsorpt
period
amount
ibv
mix
drug
ad
cell
immedi
adsorpt
inoculum
remov
dmem
supplement
fc
ad
cell
effect
ribavirin
ibv
also
test
replic
period
ad
adsorpt
typic
perform
antiibv
suscept
studi
assay
run
eight
replic
ribavirin
use
posit
control
protein
receptor
ntermin
domain
nprotein
pdb
id
rcsb
protein
data
bank
taken
without
crystal
water
molecul
conveni
name
ntd
throughout
work
geometri
partial
atom
charg
figur
taken
appli
bfg
algorithm
discov
modul
consistentval
forcefield
cvff
converg
criterion
set
kcal
demonstr
previou
literatur
explicitli
solvat
flexibl
dock
molecular
dynam
md
simul
perform
gener
popular
protocol
insightii
softwar
packag
linux
workstat
md
trajectori
gener
use
time
step
total
ps
save
interv
interact
energi
compound
ntd
respect
residu
ntd
activ
site
calcul
dock
modul
ps
md
trajectori
calcul
detail
refer
elsewher
result
express
mean
valu
standard
deviat
sd
n
signific
differ
calcul
oneway
analysi
varianc
valu
p
consid
signific
current
studi
demonstr
certain
antiibv
activ
well
inhibit
bind
process
rna
ibv
n
protein
pharmacolog
investig
necessari
provid
evid
antiibv
mechan
two
compound
